“Are You Ready for the New Era in PV?” to be Presented by ArisGlobal’s VP of Global PV at World Drug Safety Congress

Mar 28, 2019

Miami, Florida – March 28, 2019 – ArisGlobal, LLC, a leading provider of life sciences software that automates core drug development functions for over 200 life sciences companies, will present a session titled “Are You Ready for the New Era in PV?” at the upcoming World Drug Safety Congress Americas 2019  in Philadelphia, PA from April 15-17, 2019.

Aman Wasan, Vice President, Global Pharmacovigilance & Global Client Partners Group, ArisGlobal, will present the session, scheduled for April 16, 12:00-12:22 p.m., as part of the “Next Gen Tech & Data” track. Life sciences have seen many technological advances in recent years, with drug safety being at the cusp of huge changes driven by automation and increasing annual caseloads. During his session, Aman will discuss how:

  • Pharma companies are challenging their internal processes
  • Service providers are having to optimize processes to drive annual cost savings to customers
  • Safety database providers are starting to incorporate cognitive/robotic automation capabilities to redefine/optimize case processing workflow

“The huge potential to alleviate the impact of increasing adverse event case volumes, need for better compliance and quality are driving factors for pharmaceutical companies to challenge internal processes in order to incorporate technological advancements such as automation,” said Aman. “For service providers (CROs/KPOs/BPOs), who are under constant pressure to deliver annual cost reductions, these technology advancements can be the holy grail to increasing quality and productivity while reducing costs. With all these moving parts, it is imperative that the overall industry-preparedness level, including those of regulators, be raised.“

ArisGlobal is a Gold Sponsor of the conference and an exhibitor and will be showcasing LifeSphere Safety, its cognitive computing platform, in Booth #21. Attendees are invited to meet with ArisGlobal staff to learn about its innovative and leading pharmacovigilance and safety platform.

LATEST NEWS

About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn: linkedin.com/company/aris-global
Follow @Aris_Global on Twitter: twitter.com/aris_global

Contact

Alberto Cantor
ArisGlobal
+1 609-360-4042 | acantor@arisglobal.com